For 7 Days Life was Perfect with New Baby—One Phone Call Changed Everything
Summary
Lupita Vasquez’s newborn son, Jesse, was diagnosed with spinal muscular atrophy (SMA), a rare genetic disease that weakens muscles. Early detection through a routine newborn screening helped start treatment quickly, including new high-dose medication approved by the FDA.Key Facts
- Jesse was diagnosed with SMA shortly after birth through a routine heel-prick test given to most U.S. newborns.
- SMA is a genetic disease affecting nerve cells that control muscle movement, causing muscle weakness and breathing problems.
- Jesse has Type 1 SMA, the most severe form, which appears in the first six months of life.
- He began treatment at 16 days old with Evrysdi, a daily oral medicine that supports nerve function.
- Jesse also received Zolgensma, a gene therapy that replaces the faulty gene causing SMA.
- When progress was limited, his doctors prescribed a high-dose of SPINRAZA, a drug injected into the spinal fluid.
- The FDA recently approved this higher dose of SPINRAZA based on over ten years of research.
- Jesse was the first child in Texas to receive the high-dose SPINRAZA treatment.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
